FN1 and neoplasm: Anastellin displays anti-tumor, anti-metastatic, and anti-angiogenic properties in vivo and is capable of binding and converting the soluble Fn into insoluble fibrils (superfibronectin) that structurally and functionally resemble Fn deposited in the extracellular matrix by cells [23,24].